The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Berkle Sheldon since year 2005.
The trader's CIK number is 1350078.
At the time of this reporting, Berkle Sheldon is the President and CEO of
Altus Pharmaceuticals Inc.
(stock ticker symbol ALTU).
Stock purchases, sales, and option exercises reported by Berkle Sheldon since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2007-12-13
ALTU
Altus Pharmaceuticals Inc.
Option Exercise
32,000
3.92
125,440
2007-08-01
ALTU
Altus Pharmaceuticals Inc.
Sale
3,250
9.89
32,142
2007-08-01
ALTU
Altus Pharmaceuticals Inc.
Option Exercise
3,250
3.92
12,740
2007-07-19
ALTU
Altus Pharmaceuticals Inc.
Sale
8,000
11.54
92,320
2007-07-18
ALTU
Altus Pharmaceuticals Inc.
Sale
11,500
11.54
132,710
2007-07-19
ALTU
Altus Pharmaceuticals Inc.
Option Exercise
8,000
3.92
31,360
2007-07-18
ALTU
Altus Pharmaceuticals Inc.
Option Exercise
11,500
3.92
45,080
2007-04-02
ALTU
Altus Pharmaceuticals Inc.
Sale
9,750
15.03
146,542
2007-04-02
ALTU
Altus Pharmaceuticals Inc.
Option Exercise
9,750
3.92
38,220
2007-03-01
ALTU
Altus Pharmaceuticals Inc.
Option Exercise
9,750
3.92
38,220
2007-03-01
ALTU
Altus Pharmaceuticals Inc.
Sale
9,750
15.68
152,880
2007-02-01
ALTU
Altus Pharmaceuticals Inc.
Option Exercise
9,750
3.92
38,220
2007-02-01
ALTU
Altus Pharmaceuticals Inc.
Sale
9,750
18.25
177,937
2007-01-03
ALTU
Altus Pharmaceuticals Inc.
Option Exercise
9,750
3.92
38,220
2007-01-03
ALTU
Altus Pharmaceuticals Inc.
Sale
9,750
18.88
184,080
2006-12-22
ALTU
Altus Pharmaceuticals Inc.
Option Exercise
8,000
3.92
31,360
2006-12-20
ALTU
Altus Pharmaceuticals Inc.
Sale
6,500
20.07
130,455
2006-12-20
ALTU
Altus Pharmaceuticals Inc.
Option Exercise
6,500
3.92
25,480
2006-12-01
ALTU
Altus Pharmaceuticals Inc.
Sale
9,750
17.87
174,232
2006-12-01
ALTU
Altus Pharmaceuticals Inc.
Option Exercise
9,750
3.92
38,220
2006-11-01
ALTU
Altus Pharmaceuticals Inc.
Option Exercise
9,750
3.92
38,220
2006-11-01
ALTU
Altus Pharmaceuticals Inc.
Sale
9,750
16.07
156,682
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Berkle Sheldon
(President and CEO of Altus Pharmaceuticals Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.